Abstract
An intein-driven protein splicing approach allowed for the covalent linkage between the N- and C-termini of a polypeptide chain to create circular variants of the endo-β-1,3-1,4-glucanase, LicA, from Bacillus licheniformis. Two circular variants, LicA-C1 and LicA-C2, which have connecting loops of 20 and 14 amino acids, respectively, showed catalytic activities that are approximately two and three times higher, respectively, compared to that of the linear LicA (LicA-L1). The thermal stability of the circular variants was significantly increased compared to the linear form. Whereas the linear glucanase lost half of its activity after 3 min at 65 °C, the two circular variants have 6-fold (LicA-C1) and 16-fold (LicA-C2) increased half-life time of inactivation. In agreement with this, fluorescence spectroscopy and differential scanning calorimetry studies revealed that circular enzymes undergo structural changes at higher temperatures compared to that of the linear form. The effect of calcium on the conformational stability and function of the circular LicAs was also investigated, and we observed that the presence of calcium ions results in increased thermal stability. The impact of the length of the designed loops on thermal stability of the circular proteins is discussed, and it is suggested that cyclization may be an efficient strategy for the increased stability of proteins.
Keywords: Thermophilic enzyme, Circular protein, Enzyme stability, Cyclization, Thermostability
Introduction
The application of enzymes in biotechnology and biocatalysis has increased considerably over the last few decades [1–4]. Desired features for optimal performance in these applications include high specificity, increased activity, and prolonged stability at elevated temperatures. Because mesophilic enzymes have evolved to function optimally at ambient temperatures, it is not surprising that such proteins do not meet most of the chemical, physical, and biological requirements for being ideal biocatalysts. Limited shelf life and low intrinsic stability are major drawbacks for the successful biotechnological application of mesophilic enzymes. Factors contributing to thermostability include ionic or hydrophobic interactions, improved subunit interactions, reduced surface area, increased packing, kinetic, thermodynamic and dynamic (including flexibility and rigidity) factors, or a combination thereof [5–9]. Both random and directed mutagenesis strategies have been used to create variants of mesophilic and thermophilic enzymes with increased stability features [10–13].
A poorly explored approach for the stabilization of a protein is the covalent cyclization of its backbone structure. Several naturally occurring peptides and small proteins have been identified in bacteria, plants, and mammals having covalently linked N- and C-termini [14–16]. It has been demonstrated that these circular peptides and proteins not only are more stable at a broad range of chemical and physical conditions but also often show an increased resistance to proteases [17]. Although details on the biosynthesis of naturally occurring circular proteins are largely unknown, several studies have shown that it is possible to engineer a covalent linkage between the N- and C-terminal amino acids of a polypeptide chain, thereby generating a circular enzyme. Several cyclization strategies have been described: (1) a chemical approach that employs solid phase synthesis combined with chemical ligation or cross-linking [18, 19]; (2) a biochemical strategy based on intein-driven self-ligation (cis and trans) in vitro [20–22] or on sortase-catalyzed transpeptidation [23]; and (3) a biological method that is based on the ability of inteins to perform self-splicing (cis and trans) in vivo (Fig. 1) [20, 24–27].
Bacterial 1,3-1,4-β-glucanases (or lichenases, EC 3.2.1.73) hydrolyze β-1,4-glycosidic bonds on 3-O-substituted glycosyl residues in linear mixed-linked glucans, like barley β-glucan and lichenan, and have been studied extensively over the years [28]. These enzymes are classified in family 16 of glycoside hydrolases [29] and have a monomeric jelly roll β-sandwich structure (Fig. 2) [30, 31].
In this study, we used a cyclization approach to covalently link the N- and C-termini of the thermophilic endo-β-1,3-1,4-glucanase (LicA) from Bacillus licheniformis. The crystal structure of LicA shows that the N- and C-termini are in close proximity, i.e., approximately 7 Ǻ, being part of the adjacent anti-parallel beta strands (Fig. 2) [30]. This structural property of LicA allows for employing the intein-based method of protein cyclization to generate a circular backbone structure. A number of circular LicA variants were produced and tested for their biological activity and stability at elevated temperatures.
Materials and Methods
Bacterial Hosts and Vectors
The T7 expression vector pET24d was obtained from Novagen. Escherichia coli XL-1 Blue (Stratagene) was used as an initial host for cloning, while the E. coli strains BL21(DE3) and JM109 (DE3) (Stratagene) were used as expression hosts for the pET derivatives. E. coli was grown in TY medium [32] in a rotary shaker at 37 °C. Kanamycin was added to a final concentration of 30 μg/ml.
Cloning and Expression
The gene coding for B. licheniformis 1,3-1,4-β-glucanase previously cloned in the pUC119-derived pD6-2 [33] was used as a template for PCR amplification. For expression of the linear enzyme without the signal sequence, the gene was subcloned in pET24d using primers BG1306 and BG1307 (Table 1), introducing a C-terminal His-tag, resulting in pWUR146.
Table 1.
Primera | Primer sequenceb | Description | LicA variant |
---|---|---|---|
BG1260 s | GCGCGCCATGGGACATGAGTACATCTATGACAGA | Intein C + NcoI site | C1–C6, C1control |
BG1261 a | GTGGTGGTGGTGGTGGTGTCCGGTGTTGTGGACGAAAATCATTC | Intein C + His-tag | C1, C2, C6, C1control |
BG1262 s | GGACACCACCACCACCACCACCAAACGGGCGGGTCGTTTTATGAAC | Glucanase + His-tag | C1, C2, C6, C1control |
BG1263 a | CCCGGTTCCTCGTGGTACTAGTCTTTTTGTGTAACGCACCCAATG | Glucanase + thrombin site | C1, C5, C1control |
BG1264 s | CTAGTACCACGAGGAACCGGGTGCATAGACGGAAAGGCCAAG | Intein N + thrombin site | C1, C5, C1control |
BG1265 a | GCGCGCTCGAGCTTAACATGTGAGTGGTATTTATC | Intein N + XhoI site | C1control |
BG1306 s | GCGCGCCATGGGGCAAACGGGCGGGTCGTTTT | Glucanase + NcoI site + Δsignal seq + SA→MG | L1 |
BG1307 a | GCGCGCTCGAGTCTTTTTGTGTAACGCACCCA | Glucanase + XhoI site + Δstop codon | L1 |
BG1351 s | GGACACCACCACCACCACCACGGGTCGTTTTATGAACCGTTCAAC | Glucanase + His-tag + ΔQTG | C3, C4, C5 |
BG1352 a | TGGCCTTTCCGTCTATGCACCCTGTGTAACGCACCCAATGTAATGAG | Glucanase + thrombin site + Δthrombin site + ΔKR | C3, C6 |
BG1353 s | CTCATTACATTGGGTGCGTTACACAGGGTGCATAGACGGAAAGGCCA | Intein N + thrombin site + Δthrombin site + ΔKR | C3, C6 |
BG1354 a | GCGCGCTCGAGTTACTTAACATGTGAGTGGTATTTATCAAA | Intein N + XhoI site + stop codon | C1–C6 |
BG1429 a | TCTATGCACCCTCTTTTTGTGTAACGCACCCAATG | Glucanase + thrombin site + Δthrombin site | C2 |
BG1430 s | GTTACACAAAAAGAGGGTGCATAGACGGAAAGGCC | Intein N + thrombin site + Δthrombin site | C2 |
BG1431 a | CCCGGTTCCTCGTGGTACTAGTGTGTAACGCACCCAATGTAATG | Glucanase + thrombin site + ΔKR | C4 |
BG1432 s | CTAGTACCACGAGGAACCGGGTGCATAGACGGAAAGGCC | Intein N + thrombin site + ΔKR | C4 |
Intein-f a | CGAGCCGAGGACGTTCTACGATC | Forward sequence primer, annealing to intein | – |
Intein-r s | GCTTGTATCTCTCGTACATCTCCTC | Reverse sequence primer, annealing to intein | – |
a“s” in the primer denotes “sense” and “a” denotes “antisense”
bSequences are given from 5′–3′
Pyrococcus furiosus genomic DNA was isolated as described previously [32] and used as template for PCR amplification of the intein PI-PfuI [24, 34]. In a first series of PCR reactions, the two parts of the intein and the glucanase gene were amplified separately (Fig. 3a). In a subsequent PCR step, the three overlapping fragments were fused by overlap extension PCR [35], and the full-length hybrid molecule was amplified using the flanking primers BG1260 and BG1265/1354 (2.1 kb; Fig. 3a). The 2.1-kb PCR product was then ligated into pET24d at the NcoI and XhoI restriction sites and transformed to E. coli XL1-Blue. Sequence analysis of all variant constructs that were produced by this method (Table 1) was done by the dideoxynucleotide chain termination method with a Li-Cor automatic sequencing system (model 4000L). Two sets of sense/antisense sequence primers were used, which anneal either to the promoter and terminator sequence of the pET24d vector or to the sequences of the two parts of the intein flanking the glucanase gene (Intein-f and Intein-r in Table 1).
Overexpression and Purification
Both the licA-L1 gene and the permutated genes were expressed in freshly transformed BL21(DE3) or JM109 (DE3) cells. A 5-ml overnight culture was used to inoculate 500 ml of the TY medium containing 30 μg/ml kanamycin. When the OD600 reached 0.5, the cells were induced with 100 μM IPTG and subsequently grown at 37 °C for 4 h. Cells were harvested by centrifugation (10 min, 4,000×g) and resuspended in 50 mM sodium phosphate buffer (pH 7.7) containing 300 mM NaCl and 10 mM imidazole. After the addition of lysozyme to 1 mg/ml, the cells were incubated on ice for 30 min before sonication (six times for 15 s). Then, the cell debris were removed by centrifugation (30 min, 10,000×g) and the LicA variants containing a histidine hexapeptide (His-tag) were further purified from the supernatant using Ni-NTA spin columns according to the protocol for native conditions (Qiagen). The active fractions were collected and purified to homogeneity on a Superdex200 column by FPLC (Amersham Biosciences). Depending on subsequent analysis of the enzyme, elution was performed with either a 50-mM sodium phosphate buffer (pH 7.7) or a 20-mM PIPES buffer (pH 7.0).
Enzymatic Assays
Standard enzymatic assays were performed at 55 °C in 30 mM sodium phosphate buffer (pH 7.0) containing 0.1 mM of CaCl2 and barley β-glucan (final concentration, 0.4 %, w/v) as a substrate. The reducing sugars were detected by the dinitrosalicylic acid method, with glucose as the standard. One unit is defined as the amount of enzyme required to release 1 μmol of reducing sugars per minute. Temperature-induced inactivation was determined in 50 mM sodium phosphate (pH 7.7) and 1 mM CaCl2 by heating the purified enzyme (30 μg/ml) in small crimp-sealed vials, submerged in a water bath. During a time series (0–20 h), 20 μl aliquots were tested for remaining activity as described above. All activities were corrected for spontaneous hydrolysis in the absence of enzyme. In all cases, the standard errors of the enzymatic activity measurements (performed in duplicate) were <10 %.
Thrombin Digestion
To linearize the circular proteins containing a thrombin recognition site, incubation with thrombin (Sigma) was performed overnight at 22 °C. A ratio of 1 U of thrombin per 100 μg of protein was used.
Fluorescence Emission Spectroscopy
For fluorescence experiments, LicA variant proteins were purified with 20 mM PIPES buffer (pH 7.0) as the eluent in the final step on the Superdex200 column. In 10-mm Quartz SUPRASIL precision cells (Hellma), 20 mM PIPES (pH 7.0) was mixed with the protein solution to a final concentration of 15 μg/ml with a final volume of 3 ml. When indicated, 1 mM CaCl2 or 1 mM EDTA was added. Fluorescence emission was measured in the temperature range 30–90 °C, with a scan rate of 0.5 °C/min, by a Varian Cary Eclipse spectrophotometer. The emission spectra were recorded in the range 300–400 nm upon excitation of the tryptophans at 295 nm; the excitation and emission slit widths were set at 10 nm and the photomultiplier at 610 V. All spectra were corrected for the background emission of water. The emission spectra of samples containing 1 mM of either CaCl2 or EDTA were corrected using buffer baselines acquired at the same conditions.
Differential Scanning Calorimetry
Temperature-controlled calorimetric studies of 0.3 mg/ml linear LicA-L1 and circular LicA-C1 were carried out in a VP-DSC calorimeter (MicroCal Inc., Northampton, MA) using as reference the appropriate buffer. All samples were degassed for 15 min prior to loading the cells, and the enzyme solution was kept under 1.5 bar pressure to avoid boiling of the sample. The temperature increased with a heat rate of 0.5 °C/min.
Results and Discussion
Engineering a Circular LicA
To produce a circular enzyme, we used a trans-splicing intein to ligate protein backbones. The intein PI-PfuI from P. furiosus has been demonstrated to perform this cyclization in E. coli [24]; therefore, it was selected for the present study. In a two-step PCR reaction, we connected the C-terminal part of the intein (residues 161–454) to the N-terminus of the mature endo-1,3-1,4-β-glucanase and the N-terminal part (residues 1–160) to the C-terminus of the endo-1,3-1,4-β-glucanase (Fig. 3a). After cloning in pET24d, we produced a chimeric gene of 2,058 bp coding for a precursor protein with a total length of 686 amino acids (79.4 kDa), which did not contain the signal sequence of the wild-type LicA to ensure that splicing occurred intracellularly.
To facilitate purification of the LicA variants, a His-tag was introduced at the N-terminus of the glucanase. Furthermore, the connecting loop contained a thrombin recognition site (LVPRGT) to enable subsequent linearization and production of the LicA-L1 linear glucanase by thrombin cleavage (Fig. 3c).
Upon the addition of thrombin to the purified spliced LicA-C1 protein and overnight incubation, SDS-PAGE analysis showed a migration behavior of the thrombin-digested sample (linear LicA-L1; Fig. 4b, lane 2) which was different from that of the untreated LicA-C1 protein (Fig. 4b, lane 1). The non-digested circular LicA-C1 protein migrates faster, as expected for a circular form. It is anticipated that in denaturing conditions, the circular enzyme is likely to retain a more compact (less unfolded) conformation compared to that of the thrombin-linearized form of the enzyme. This phenomenon has been reported previously for other circular and linearized polypeptides [22, 24, 25]. After thrombin treatment, the linear LicA-L1 consists of 224 amino acids, whereas the circular protein LicA-C1 has a length of 229 amino acids (Fig. 3b, c).
After purification, LicA-L1 has a specific activity of 2.7 U/mg against barley-β-glucan, which is similar to that of wild-type LicA expressed with the signal sequence [36]. This indicates that both the loss of the signal peptide (29 amino acids) and the addition of the His-tag (Fig. 3b) to the peptide backbone do not affect the specific activity of LicA.
After purification, SDS-PAGE gel analysis of cell-free extracts from E. coli BL21(DE3) cells overproducing LicA-C1 showed a single fragment of size 27 kDa corresponding to the molecular weight of the mature circular LicA-C1 with the C- and N-terminal parts of the intein spliced out (Fig. 4a, lane 3). Because neither of the intein fragments contains a His-tag, they will be lost during affinity chromatography. This allows for a convenient one-step purification of the produced circular LicAs.
As a splicing control, an additional construct was made, i.e., LicA-C1control, which is identical to LicA-C1, except that a second His-tag was introduced to the N-terminal part of the intein. In this case, SDS-PAGE analysis of the purified proteins revealed three bands with sizes of 35, 27, and 19 kDa (Fig. 4a, lane 4). The sizes correspond to the expected molecular weights of the LicA-C1 and of the C- and N-terminal parts of the intein. This suggests that the splicing reaction which occurred inside the cells leads to three separate polypeptide fragments. Moreover, the co-purification on the Ni-NTA column shows that the C-terminal part of the intein, lacking a His-tag, is associated with its N-terminal part, which is necessary for the splicing reaction. A similar phenomenon was observed by Iwai et al. [24] who also reported the presence of an unprocessed 80-kDa product. The absence of such an unprocessed form in our system indicates the efficiency of the present approach.
Different Loop Designs
The cell-free extracts containing the circular protein LicA-C1 showed hydrolytic activity on barley-β-glucan, reflecting its proper folding. After purification, the specific activity of the circular enzyme LicA-C1 was calculated to be approximately two times higher compared to that of the linear LicA-L1 glucanase (Fig. 3c). To investigate the effect of the introduced loop on LicA’s biological activity, a series of constructs with different lengths and composition were designed. Shorter loops were constructed either by deletion of three N-terminal residues (QTG), two C-terminal residues (KR), the thrombin recognition site (LVPRGT), or a combination thereof, resulting in linking loops consisting of 9–20 amino acid residues (Fig. 3c). The six histidine residues were always maintained to facilitate purification. Based on SDS-PAGE analysis and biological activity assays of Ni-NTA-purified samples of the complete set of clones, it was concluded that not all circular variants were functionally produced. In the cases of LicA-C3, LicA-C4, and LicA-C6, no LicA protein was observed in the soluble fraction of E. coli lysates, and no activity was detected (Fig. 3c).
The two variants with the shortest loop (i.e., LicA-C3 and LicA-C6) were inactive, whereas the ones with the longest loop (LicA-C1 and LicA-C5) show significant hydrolytic activity (Fig. 3c). Circular LicAs with medium-sized loops presented an active (i.e., LicA-C2) and an inactive (i.e., LicA-C4) variant, which suggests that the loop length is not the only factor affecting biological function and that the C-terminal residues (KR) could be important for the stability of the circular enzyme. Further work will be required to elucidate the role of the C-terminal residues on the LicAs enzymatic activity. Removal of the N-terminal QTG or the thrombin recognition site has not any effect on the activity. Overall, it is concluded that both the length of the loop and the nature of amino acid residues in the region adjacent to the C-terminus determine the efficiency of intein processing which is required to generate active circular LicAs.
The variant with the shortest loop that was still active, LicA-C2, was compared with the long-loop variant, LicA-C1, with respect to temperature of optimal activity and thermal stability. The optimal temperature of hydrolytic activity for both spliced proteins was determined to be 56 °C, which is identical to the 56 °C optimum of the linear enzyme and to the 55 °C optimum of the wild-type enzyme [36]. However, the circular variants are more stable than the linear enzyme. Upon incubation at 65 °C, LicA-C1 inactivated sixfold slower than LicA-L1, whereas LicA-C2, the other circular variant with the shorter linker loop (Fig. 3c), showed an inactivation half-life time of 50 min at 65 °C, which implies a 16-fold increase compared to the inactivation half-life of the linear enzyme (Fig. 5).
The difference in stability between the two circular variants is significant. LicA-C2 differs from LicA-C1 by the deletion of six amino acids, corresponding to the thrombin recognition site from the connecting loop (Fig. 3c). The shorter loop of LicA-C2 might result in a more stable protein because it is more compact, whereas it is likely that the longer loop of LicA-C1 is more flexible, which renders the protein more susceptible to unfolding at elevated temperatures. Solving the three-dimensional structures of LicA-C1 and LicA-C2 would be required to reveal interactions between residues in the loop and other residues that might contribute to the stability of the circular enzymes.
Fluorescence spectroscopy after excitation at 295 nm showed similar emission spectra for the linear LicA-L1 and the circular LicA-C1, LicA-C2, and LicA-C5 proteins (not shown), confirming their correct folding. From these results, we conclude that circular LicA was expressed, excised, and ligated successfully to acquire its designed circular backbone. Furthermore, the increased activities of the circular enzyme variants LicA-C1, LicA-C2, and LicA-C5 compared to the linear LicA-L1 suggest that the introduced junction and loop do not result in activity loss of the enzyme. Earlier studies have shown that circular permutations in the compact jelly roll domain of LicA are tolerated and did not result in significant changes in the enzymatic activity or tertiary structure [37, 38]. Therein, it was shown that the direct peptide bond linking of the N- and C-termini, without the addition of extra residues, did not introduce strain into the molecule. However, in those studies, new N- and C-termini were introduced in another loop of the glucanase structure, and as such there was still an open-chain (linear) structure, which might enable the release of the strain. In our study, a covalently closed circular polypeptide chain was generated, resulting in increased specific enzymatic activity without introducing a severe strain.
Thermal Stability of Circular LicA
Temperature-induced unfolding was monitored by fluorescence spectroscopy to determine the transition midpoint and study the effect of cyclization on protein stability. LicA contains eight tryptophan residues randomly distributed over the protein backbone which were used as intrinsic probes for fluorescence emission studies. The fluorescence intensity of the linear and circular LicAs was monitored at 345 nm upon excitation at 295 nm as a function of temperature (Fig. 6). Upon increasing the temperature of the enzyme solution, the fluorescence intensity decreased and a red shift of the maximum fluorescence intensity was observed. The decrease in fluorescence was due to the unfolding of the tertiary structure of the enzyme. Data analysis showed that there is a clear effect of circularization toward stabilization of LicA. The circular glucanases unfolded at higher temperatures compared to the linear enzyme. In the presence of 1 mM CaCl2, the observed transition for LicA-L1 was determined to be at 62.6 ± 0.2 °C. The respective transitions for the circular LicA-C1 and LicA-C2 were 66.4 ± 0.1 and 69.0 ± 0.2 °C, respectively (Fig. 6).
Furthermore, the thermal unfolding of the linear LicA-L1 and circular LicA-C1 was studied by calorimetry. Differential scanning calorimetry (DSC) studies revealed a single transition peak in both cases. The denaturation temperatures, T d, were found to be 60.2 and 62.4 °C for LicA-L1 and LicA-C1, respectively (Fig. 7). These results are in good agreement with the transitions observed from monitoring the fluorescence intensity as a function of temperature at the same buffer conditions. Varying the scanning rate between 0.25 and 1.5 °C/min did not affect the T d or the shape of the endothermal peak. As judged by the shape of the post-transition peak, it is suggested that heat denaturation results in protein aggregation. Furthermore, after cooling the samples to room temperature, subsequent heating up did not reveal a denaturation peak, which suggests irreversible unfolding. The difference in the transition temperature observed by fluorescence spectroscopy and DSC was expected because fluorescence spectroscopy monitors changes in the Trp microenvironment and therefore may be considered as a more sensitive method to monitor structural changes compared to calorimetry, in which a transition is recorded only when the protein unfolds locally or globally.
These results are in line with the results from comparing the thermal inactivation of LicA-C1 with that of LicA-L1 (Fig. 5). Incubation at 65 °C caused the linear enzyme to inactivate very rapidly (t 1/2 = 3 min); complete inactivation occurred within 15 min. The circular LicA-C1, however, retained half of its initial activity even after 20 min (Fig. 5) at 65 °C, i.e., a sixfold increase compared to the linear LicA-L1. Taken together, the results of DSC, fluorescence spectroscopy, and biological activity tests suggest that backbone cyclization increases the internal stability of LicA-C1.
The Effect of Calcium on the Thermal Stability of Circular LicA
The effect of calcium on the thermal stability of the linear and circular LicAs was examined by fluorescence spectroscopy. The addition of 1 mM EDTA caused the linear enzyme to denature at 59.8 ± 0.2 °C, which is lower compared to the melting temperature of 62.6 ± 0.2 °C that was observed in the presence of calcium (Figs. 6 and 8). This finding confirmed the stabilizing effect of calcium on LicAs, as reported previously for other members of the GH-16 family [39, 40]. In the presence of 1 mM EDTA, the circular LicA-C1 showed a melting temperature of 62.8 ± 0.2 °C, a decrease of 3.6 °C compared to the transition of 66.4 ± 0.1 °C which was observed in the presence of 1 mM CaCl2 (Figs. 6 and 8).
The apparent melting temperatures determined for the linear and circular enzymes agree with the deactivation of the glucanases at 65 °C (Fig. 5). In the presence of calcium ions, the melting temperature of the linear enzyme is at 62.6 °C; therefore, at 65 °C, in which the activity tests were performed, denaturation occurs rapidly. However, 65 °C is below the circular enzyme’s denaturation temperature (i.e., 66.4 °C for LicA-C1), resulting in a slower inactivation process.
In summary, the endo-1,3-1,4-β-glucanase from B. licheniformis was successfully circularized using the cyclization approach based on circular permutation of a precursor protein flanked by two intein domains. The circular variants presented activity properties which were up to three times higher than that of the linear enzyme; moreover, they were significantly more stable at elevated temperatures. It is anticipated that apart from the stabilization effect of cyclization against heat and chemical treatment, circular enzyme variants would be more resistant toward exo-proteases compared to respective linear enzyme, as shown previously [17]. Successful implementation of thermozymes to numerous applications in biotechnology and biocatalysis depends on their ability to retain biological activity for prolonged periods of time upon exposure to high-temperature conditions. Although the design of the connecting loop will differ depending on the specific protein, the results presented in this study suggest that cyclization may be an effective tool to stabilize proteins and enzymes.
Acknowledgments
This research was supported by the Technology Foundation (STW) Applied Science Division of NWO and the technology program of the Ministry of Economic Affairs. O.P. received a fellowship of the VLAG graduate school (Wageningen University).
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Abbreviations
- LicA
Endo-β-1,3-1,4-glucanase
- DSC
Differential scanning calorimetry
Contributor Information
John van der Oost, Email: john.vanderoost@wur.nl.
Sotirios Koutsopoulos, Phone: +1-617-3247612, FAX: +1-617-2585239, Email: sotiris@mit.edu.
References
- 1.Kirk O, Borchert TV, Fuglsang CC. Current Opinion in Biotechnology. 2002;13:345–351. doi: 10.1016/S0958-1669(02)00328-2. [DOI] [PubMed] [Google Scholar]
- 2.Schmid A, Dordick JS, Hauer B, Kiener A, Wubbolts M, Witholt B. Nature. 2001;409:258–268. doi: 10.1038/35051736. [DOI] [PubMed] [Google Scholar]
- 3.van Beilen JB, Li Z. Current Opinion in Biotechnology. 2002;13:338–344. doi: 10.1016/S0958-1669(02)00334-8. [DOI] [PubMed] [Google Scholar]
- 4.Unsworth LD, van der Oost J, Koutsopoulos S. FEBS Journal. 2007;274:4044–4056. doi: 10.1111/j.1742-4658.2007.05954.x. [DOI] [PubMed] [Google Scholar]
- 5.van den Burg B, Eijsink VG. Current Opinion in Biotechnology. 2002;13:333–337. doi: 10.1016/S0958-1669(02)00325-7. [DOI] [PubMed] [Google Scholar]
- 6.Yip KS, Britton KL, Stillman TJ, Lebbink J, de Vos WM, Robb FT, Vetriani C, Maeder D, Rice DW. European Journal of Biochemistry. 1998;255:336–346. doi: 10.1046/j.1432-1327.1998.2550336.x. [DOI] [PubMed] [Google Scholar]
- 7.Koutsopoulos S, van der Oost J, Norde W. FEBS Journal. 2007;274:5915–5923. doi: 10.1111/j.1742-4658.2007.06114.x. [DOI] [PubMed] [Google Scholar]
- 8.Luke K, Higgins C, Wittung-Stafshede P. FEBS Journal. 2007;274:4023–4033. doi: 10.1111/j.1742-4658.2007.05955.x. [DOI] [PubMed] [Google Scholar]
- 9.Koutsopoulos S, van der Oost J, Norde W. Proteins. 2005;61:377–384. doi: 10.1002/prot.20606. [DOI] [PubMed] [Google Scholar]
- 10.Kaper T, Lebbink JH, Pouwels J, Kopp J, Schulz GE, van der Oost J, de Vos WM. Biochemistry. 2000;39:4963–4970. doi: 10.1021/bi992463r. [DOI] [PubMed] [Google Scholar]
- 11.Kaper T, Brouns SJ, Geerling AC, de Vos WM, van der Oost J. Biochemistry Journal. 2002;368:461–470. doi: 10.1042/BJ20020726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lebbink JH, Kaper T, Bron P, van der Oost J, de Vos WM. Biochemistry. 2000;39:3656–3665. doi: 10.1021/bi991483q. [DOI] [PubMed] [Google Scholar]
- 13.Machius M, Declerck N, Huber R, Wiegand G. Journal of Biological Chemistry. 2003;278:11546–11553. doi: 10.1074/jbc.M212618200. [DOI] [PubMed] [Google Scholar]
- 14.Craik DJ, Daly NL, Saska I, Trabi M, Rosengren KJ. Journal of Bacteriology. 2003;185:4011–4021. doi: 10.1128/JB.185.14.4011-4021.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Trabi M, Craik DJ. Trends in Biochemical Sciences. 2002;27:132–138. doi: 10.1016/S0968-0004(02)02057-1. [DOI] [PubMed] [Google Scholar]
- 16.Gillon AD, Saska I, Jennings CV, Guarino RF, Craik DJ, Anderson MA. The Plant Journal. 2008;53:505–515. doi: 10.1111/j.1365-313X.2007.03357.x. [DOI] [PubMed] [Google Scholar]
- 17.Craik DJ, Cemazar M, Wang CK, Daly NL. Biopolymers. 2006;84:250–266. doi: 10.1002/bip.20451. [DOI] [PubMed] [Google Scholar]
- 18.Camarero JA, Pavel J, Muir TW. Angewandte Chemie International Edition. 1998;37:347–349. doi: 10.1002/(SICI)1521-3773(19980216)37:3<347::AID-ANIE347>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
- 19.Goldenberg DP, Creighton TE. Journal of Molecular Biology. 1983;165:407–413. doi: 10.1016/S0022-2836(83)80265-4. [DOI] [PubMed] [Google Scholar]
- 20.Camarero JA, Muir TW. Journal of the American Chemical Society. 1999;121:5597–5598. doi: 10.1021/ja990929n. [DOI] [Google Scholar]
- 21.Evans TC, Martin D, Kolly R, Panne D, Sun L, Ghosh I, Chen LX, Benner J, Liu XQ, Xu MQ. Journal of Biological Chemistry. 2000;275:9091–9904. doi: 10.1074/jbc.275.13.9091. [DOI] [PubMed] [Google Scholar]
- 22.Iwai H, Pluckthun A. FEBS Letters. 1999;459:166–172. doi: 10.1016/S0014-5793(99)01220-X. [DOI] [PubMed] [Google Scholar]
- 23.Antos JM, Popp MWL, Ernst R, Chew GL, Spooner E, Ploegh HL. Journal of Biological Chemistry. 2009;284:16028–16036. doi: 10.1074/jbc.M901752200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Iwai H, Lingel A, Pluckthun A. Journal of Biological Chemistry. 2001;276:16548–16554. doi: 10.1074/jbc.M011639200. [DOI] [PubMed] [Google Scholar]
- 25.Scott CP, Abel-Santos E, Wall M, Wahnon DC, Benkovic SJ. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:13638–13643. doi: 10.1073/pnas.96.24.13638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Siebold C, Erni B. Biophysical Chemistry. 2002;96:163–171. doi: 10.1016/S0301-4622(02)00012-1. [DOI] [PubMed] [Google Scholar]
- 27.Williams NK, Liepinsh E, Watt SJ, Prosselkov P, Matthews JM, Attard P, Beck JL, Dixon NE, Otting G. Journal of Molecular Biology. 2005;346:1095–1108. doi: 10.1016/j.jmb.2004.12.037. [DOI] [PubMed] [Google Scholar]
- 28.Planas A. Biochimica et Biophysica Acta. 2000;1543:361–382. doi: 10.1016/S0167-4838(00)00231-4. [DOI] [PubMed] [Google Scholar]
- 29.Henrissat B. Biochemistry Journal. 1991;280:309–316. doi: 10.1042/bj2800309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hahn M, Pons J, Planas A, Querol E, Heinemann U. FEBS Letters. 1995;374:221–224. doi: 10.1016/0014-5793(95)01111-Q. [DOI] [PubMed] [Google Scholar]
- 31.Keitel T, Simon O, Borriss R, Heinemann U. Proceedings of the National Academy of Sciences of the United States of America. 1993;90:5287–5291. doi: 10.1073/pnas.90.11.5287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1989. [Google Scholar]
- 33.Planas A, Juncosa M, Lloberas J, Querol E. FEBS Letters. 1992;308:141–145. doi: 10.1016/0014-5793(92)81262-K. [DOI] [PubMed] [Google Scholar]
- 34.Ichiyanagi K, Ishino Y, Ariyoshi M, Komori K, Morikawa K. Journal of Molecular Biology. 2000;300:889–901. doi: 10.1006/jmbi.2000.3873. [DOI] [PubMed] [Google Scholar]
- 35.Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Gene. 1989;77:51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
- 36.Lloberas J, Querol E, Bernues J. Applied Microbiology and Biotechnology. 1988;29:32–38. doi: 10.1007/BF00258347. [DOI] [Google Scholar]
- 37.Aÿ J, Hahn M, Decanniere K, Piotukh K, Borriss R, Heinemann U. Proteins. 1998;30:155–167. doi: 10.1002/(SICI)1097-0134(19980201)30:2<155::AID-PROT5>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
- 38.Hahn M, Piotukh K, Borriss R, Heinemann U. Proceedings of the National Academy of Sciences of the United States of America. 1994;91:10417–10421. doi: 10.1073/pnas.91.22.10417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chiaraluce R, Gianese G, Angelaccio S, Florio R, van Lieshout JF, van der Oost J, Consalvi V. Biochemistry Journal. 2004;386:515–524. doi: 10.1042/BJ20041137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Keitel T, Meldgaard M, Heinemann U. European Journal of Biochemistry. 1994;222:203–214. doi: 10.1111/j.1432-1033.1994.tb18858.x. [DOI] [PubMed] [Google Scholar]